Last updated on February 2015

Safety and Pharmacokinetic Characteristics of DKF-313


Brief description of study

This is a randomized, open-label, single-dose, 2-treatment, 2-way, 2-period crossover study to evaluate the safety and the pharmacokinetic characteristics of DKF-313 (dutasteride and tadalafil) in healthy male volunteers.

Detailed Study Description

This study is conducted to evaluate the pharmacokinetics of DKF-313 (dutasteride and tadalafil) comparing with the concomitant administration of AVODART and CIALIS in healthy male volunteers.

Clinical Study Identifier: NCT02352311

Contact Investigators or Research Sites near you

Start Over

Min-Gul Kim, M.D.

Chonbuk National University Hospital
Jeonju, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.